Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Pharma
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
The TROP2 ADC also awaits an FDA decision in EGFR-mutated lung cancer and a key readout in first-line non-small cell lung cancer in 2025.
Angus Liu
Jan 17, 2025 9:14pm
AZ's Calquence, Amgen's Lumakras win new FDA green lights
Jan 17, 2025 11:11am
CMS picks 2nd batch of drugs for IRA price talks
Jan 17, 2025 9:28am
Where is the industry going with its rush to radiopharma?
Jan 10, 2025 3:00am
J&J's Rybrevant-Lazcluze tops AZ's Tagrisso on overall survival
Jan 7, 2025 8:00am
Roche-Innovent, AstraZeneca, Viatris and more—Fierce Pharma Asia
Jan 3, 2025 8:37am
